Chennai, July 19 (FN Agency) For the first time in India CSIR-CECRI (Central Electrochemical Research Institute) and GODI India have entered into a public-private partnership through a MoA, to operate and maintain advanced Lithium-ion cells manufacturing facility at Taramani in Chennai city. Dr Shekhar C Mande, Former Secretary DSIR and Former Director General, CSIR inaugurated the facility in the presence of Dr Kalaiselvi, Director, CECRI today. Speaking on the occasion, Shekhar Mande said “CSIR is a treasure of knowledge covering all facets of science. CSIR is contributing a lot in the space, defence, nuclear and other societal applications. Partnering with GODI India marks a new chapter in the development of advanced Lithium-ion cells with regard to next generation of energy storage applications.
“We have taken a step further to provide fruitful contribution to the ultimate benefit of the country under ‘Atmanirbhar Bharat”, he added. Kalaiselvi said “It is a glorious occasion for India in the area of energy storage for manufacturing Lithium-ion cells initiated by CECRI in partnership with GODI India Private Limited in presence of Shekhar Mande”. Mahesh Godi, Founder and CEO, GODI India, said This partnership is just a beginning of development of next generation cells for mobility, ESS applications and new R&D projects. GODI India will operate and maintain the facility to manufacture advance Lithium-ion cells and cater to various applications ranging from e-mobility to large scale energy storage systems.
“This partnership signifies our credibility and testimony of technology strength in Lithium-ion cells manufacturing,” he added. Sharing details about the Lithium-ion market, Mahesh said “currently, all the Lithium-ion cells are being imported mostly from China and South Korea. GODI India is the first Indian company to manufacture Made-in-India and Made-for-India Lithium-ion cells, which is certified by BIS (Bureau of Indian Standards), tested and qualified by TUV, the third party testing agency. With this, GODI India can manufacture and sell the cells on par to the standard cells available in the world market, he said.